Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity - Nature.com

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity  Nature.comStudy demonstrates substantial immune response in individuals infected with SARS-CoV-2 Omicron variant  News-Medical.NetImmunotherapeutic PolyTope® from ImmunoPrecise (IPA) Potently Neutralizes the SARS-CoV-2 Omicron Variant – Moves Towards FDA/IND-Submission  Business WireDaily briefing: T cells — an unsung defence against COVID-19  Nature.comDeveloping